Form 4: Sera Prognostics Director Joshua Phillips Reports Significant Equity Grant

Sentiment:

Insider Transaction Report


Sera Prognostics Director Joshua Phillips has reported the acquisition of 15,596 restricted stock units and 25,000 stock options, granted as part of his compensation, vesting monthly over one year.

Summary

  • Joshua Phillips, a Director of Sera Prognostics, Inc. (SERA), reported new equity grants on June 5, 2025.
  • Phillips acquired 15,596 shares of Class A Common Stock in the form of Restricted Stock Units (RSUs) at a grant price of $0.
  • These RSUs will vest monthly over one year, commencing June 5, 2025, contingent on Phillips' continued service to the issuer.
  • Following this transaction, Phillips beneficially owns 57,005 shares of Class A Common Stock.
  • Additionally, Phillips was granted 25,000 stock options with an exercise price of $1.6 per share.
  • These stock options also vest monthly over one year, starting June 5, 2025, and have an expiration date of June 5, 2035.
  • The grants were made pursuant to Sera Prognostics, Inc.'s Non-Employee Director Compensation Policy and its 2021 Equity Incentive Plan.

Sentiment

Score: 7

Explanation: The filing indicates a standard equity compensation grant to a director, which aligns the director's interests with those of shareholders and is a positive sign of continued commitment. It's a routine transaction with no negative implications.

Positives

  • Director Joshua Phillips received a significant equity grant, which aligns his financial interests with those of the company's shareholders.
  • The grant includes both restricted stock units and stock options, providing a mix of immediate and long-term incentives for the director.
  • The vesting schedule, tied to continued service, encourages long-term commitment and engagement from the director.

Future Outlook

The vesting schedule for both RSUs and stock options extends over one year, with monthly installments commencing June 5, 2025, contingent on the reporting person's continued service to the issuer, indicating an expectation of ongoing commitment.

Industry Context

This Form 4 filing details an individual insider transaction, specifically an equity grant to a director, which is a standard practice for executive and director compensation across various industries to align interests with shareholders and incentivize long-term performance.

Comparison to Industry Standards

  • This Form 4 filing is a regulatory disclosure of an insider equity grant and does not contain information for direct comparison to specific industry benchmarks, comparable companies, projects, or their results. Director compensation structures, while common, vary significantly across companies and industries.

Related Party Transactions

  • The equity grant to Director Joshua Phillips, consisting of 15,596 Restricted Stock Units and 25,000 stock options, is a related party transaction as it represents compensation from Sera Prognostics, Inc. to a member of its board of directors.

Stakeholder Impact

  • Shareholders: The equity grant aligns the financial interests of Director Joshua Phillips with those of the company's shareholders, potentially encouraging decisions that enhance long-term shareholder value.

Next Steps

  • Continued vesting of the 15,596 RSUs and 25,000 stock options over the next year, contingent on Director Joshua Phillips' continued service to Sera Prognostics, Inc.
  • Potential future exercise of stock options by Joshua Phillips, subject to vesting and market conditions, up until the expiration date of June 5, 2035.

Key Dates

DateDescription
06/05/2025Date of transaction for the acquisition of RSUs and stock options, and the vesting commencement date for both.
06/06/2025Date the Form 4 was signed by the attorney-in-fact.
06/05/2035Expiration date of the granted stock options.

Keywords

Sera Prognostics, SERA, Form 4, Insider Transaction, Director Compensation, Equity Grant, Restricted Stock Units, Stock Options, Joshua Phillips

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.